Effect of Semaglutide on Non-alcoholic fatty liver disease using non-invasive magnetic resonance imaging (MRI) methods and exploratory biomarkers
Latest Information Update: 29 Jan 2021
At a glance
- Drugs Semaglutide (Primary)
- Indications Non-alcoholic fatty liver disease
- Focus Therapeutic Use
- 29 Jan 2021 New trial record